Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.

Nivolumab alone superior to ipilimumab alone in advanced melanoma

Dr Pier Francesco Ferrucci - European Institute of Oncology, Milan, Italy
Nivolumab alone superior to ipilimumab alone in advanced melanoma ( Dr Pier Francesco Ferrucci - European Institute of Oncology, Milan, Italy )
8 Jun 2015

New dexamethasone combination yields two-fold improvement in median PFS in multiple myeloma

Prof Meletios Dimopoulos - University of Athens, Athens, Greece
New dexamethasone combination yields two-fold improvement in median PFS in multiple myeloma ( Prof Meletios Dimopoulos - University of Athens, Athens, Greece )
5 Jun 2015

Survival benefits following eribulin in advanced liposarcoma and leiomyosarcoma

Dr Patrick Schöffski - University Hospitals Leuven, Leuven, Belgium
Survival benefits following eribulin in advanced liposarcoma and leiomyosarcoma ( Dr Patrick Schöffski - University Hospitals Leuven, Leuven, Belgium )
5 Jun 2015

ASCO 2015: Latest developments in multiple myeloma

Prof Philippe Moreau, Prof Sagar Lonial, Prof Meletios Dimopoulos
ASCO 2015: Latest developments in multiple myeloma ( Prof Philippe Moreau, Prof Sagar Lonial, Prof Meletios Dimopoulos )
1 Jun 2015

Adjuvant denosumab may preserve bone health in postmenopausal breast cancer patients: results of the ABCSG-18 trial

Prof Michael Gnant - Medical University of Vienna, Vienna, Austria
Adjuvant denosumab may preserve bone health in postmenopausal breast cancer patients: results of the ABCSG-18 trial ( Prof Michael Gnant - Medical University of Vienna, Vienna, Austria )
1 Jun 2015

Randomised trial of pembrolizumab versus standard treatment in patients with recurrent or metastatic head and neck cancer

Dr Kevin Harrington - Institute of Cancer Research, London, UK
Randomised trial of pembrolizumab versus standard treatment in patients with recurrent or metastatic head and neck cancer ( Dr Kevin Harrington - Institute of Cancer Research, London, UK )
1 Jun 2015

ASCO 2015: Latest in chronic lymphocytic leukaemia

Prof Stephan Stilgenbauer and Dr Jacqueline Barrientos
ASCO 2015: Latest in chronic lymphocytic leukaemia ( Prof Stephan Stilgenbauer and Dr Jacqueline Barrientos )
1 Jun 2015

Cobimetinib plus vemurafenib for advanced BRAF-mutated melanoma

Dr James Larkin - Royal Marsden Hospital, London, UK
Cobimetinib plus vemurafenib for advanced BRAF-mutated melanoma ( Dr James Larkin - Royal Marsden Hospital, London, UK )
1 Jun 2015

Initial nivolumab-based treatment halts melanoma progression

Dr Jedd Wolchok - Memorial Sloan-Kettering Cancer Center, New York, USA
Initial nivolumab-based treatment halts melanoma progression ( Dr Jedd Wolchok - Memorial Sloan-Kettering Cancer Center, New York, USA )
1 Jun 2015

New intelligence network that supports efforts to improve quality of care and development of new medicines

Dr Allen Lichter, Chief Executive Officer, ASCO, USA
New intelligence network that supports efforts to improve quality of care and development of new medicines ( Dr Allen Lichter, Chief Executive Officer, ASCO, USA )
1 Jun 2015

Non-randomised clinical trial aims to describe the safety and efficacy of commercially available, targeted anticancer drugs

Dr Richard Schilsky - University of Chicago, Chicago, USA
Non-randomised clinical trial aims to describe the safety and efficacy of commercially available, targeted anticancer drugs ( Dr Richard Schilsky - University of Chicago, Chicago, USA )
1 Jun 2015

Advanced DNA sequencing test used to match rare cancers

Dr James Doroshow, Dr Keith Flaherty and Dr Barbara Conley
Advanced DNA sequencing test used to match rare cancers ( Dr James Doroshow, Dr Keith Flaherty and Dr Barbara Conley )
1 Jun 2015